Granted Patent
B2
US 9,447,383 · App. 14/711,489 · Granted Sep 20, 2016
MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells
Inventors:
Yong Wook Park (Gyeonggi-Do, KR); Kun Se Lee (Seoul, KR); Bong-Yong Lee (Seoul, KR); Mahnhoon Park (Gyeonggi-Do, KR); Hun Kim (Gyeonggi-Do, KR); Yun-Hee Kim (Gyeonggi-Do, KR); Su-Jeen Lee (Gyeongg-Do, KR)
Assignee:
SK Chemicals Co., Ltd.
C12N7/00A61K39/12A61K39/145C12N5/0686A61K39/00A61K2039/525A61K2039/5254C12N2500/90C12N2760/16134C12N2760/16151C12N2760/16152C12N2760/16171C12N2760/16234C12N2760/16251C12N2760/16252C12N2760/16271
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Disclosed is a Madin-Darby canine kidney (MDCK)-derived cell line. The MDCK-derived cell line is derived from MDCK cells deposited under accession number ATCC CCL-34. The MDCK-derived cell line can be prepared by serum-free culture and suspension culture. Preferably, the MDCK-derived cell line has low or no tumorigenicity. The MDCK-derived cell line is preferably selected from MDCK Sky1023, MDCK Sky10234 and MDCK Sky3851. Further disclosed are a culture method for growing the MDCK-derived cells and a method for producing a vaccine virus using the MDCK-derived cells.
Claims (1)
1. A MDCK-derived cell line which is MDCK Sky1023 (DSM ACC3112), MDCK Sky10234 (DSM ACC3114) or MDCK Sky3851 (DSM ACC3113).
Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 18, 2018
From: SK CHEMICALS CO., LTD.
To: SK BIOSCIENCE CO., LTD.
Reel/Frame 047218/0676 →
CHANGE OF NAME
Recorded Sep 20, 2018
From: SK CHEMICALS CO., LTD.
To: SK DISCOVERY CO., LTD.
Reel/Frame 047115/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 23, 2018
From: SK DISCOVERY CO., LTD.
To: SK CHEMICALS CO., LTD.
Reel/Frame 046217/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 2, 2015
From: PARK, YONG WOOK; LEE, KUN SE; LEE, BONG-YONG; PARK, MAHNHOON; KIM, HUN; KIM, YUN-HEE; LEE, SU-JEEN
To: SK CHEMICALS CO., LTD.
Reel/Frame 036478/0838 →
Priority Claims (1)
KR 10-2011-0085902
· Aug 26, 2011
· national
Continuity (3)
Continuation
PCTKR2011006589
· Sep 6, 2011